RxDoctor Payments Data

Shruti Jolly, MD

Radiation Oncology · Ann Arbor, MINPI 1780892174

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $20,638 of the $30,387 with a category attached, or 67.9%. AstraZeneca accounts for 62.3% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2019 at $14,205 and has fallen 98.5% since, to $213 in 2023. Among radiation oncology clinicians in MI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$30,387in general payments, 2019–2025

Across 29 payments — averaging $1047.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$19K
  • Varian Medical Systems, Inc.$8K
  • GSK$2K
  • Astrazeneca UK Limited$1K
  • Reflexion Medical, Inc.$213
  • Isoray, Inc$106
  • plus $100 from 1 others
$100,165in research payments, 2019–2025

Across 6 payments — averaging $16,694 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • AstraZeneca$75K
  • EMD Serono, Inc.$25K

What the payments were for

  • Consulting fees$20,63868%
  • Speaking & faculty fees$7,80026%
  • Travel & lodging$1,0553%
  • Food & beverage$8723%
  • Education$220%

General payments by program year

19
20
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$30,387 in reported general payments places this provider in the 95th percentile of 198 radiation oncology providers in Michigan.

See all radiation oncology providers in Michigan

Medicare billing

Part B allowed, 2024
$64,820
Medicare patients
75
Services billed
582

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other radiation oncology in Ann Arbor

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →